Aegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for Biomedical Research Academy of Athens. The board both invites and approves unsolicited proposals for Conferences in all fields of Science, Engineering, Arts, and Humanities. The purpose of the Conferences is to bring together individuals with common interests to examine the emerging and most advanced aspects of their particular field. The Symposium on Ovarian Cancer: State of the Art and Future Directions intends to bring together international experts interested in the development of novel diagnostic, prognostic and therapeutic tools for ovarian cancer. The meeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities.
This book is an excellent resource on the international state-of-the-art in the diagnosis and management of ovarian cancer and is aimed at oncologists, gynecologists, and fellows.
"Whether you're a newly diagnosed ovarian cancer patient, a survivor, or a friend or relative of either, this book offers help.
In den letzten Jahren kam es zu einem noch nie dagewesenen Anstieg unseres Wissens über das Management des Ovarialkarzinoms; von Diagnose und Genetik bis hin zur Operation und neuen zielgerichteten Behandlungsmethoden.
This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine.
Susan Gubar. but a powerful exposé of the failure of medical science to find better ways to detect and treat it.” —Kirkus Reviews “Gubar's passionate and brave polemic is critical reading for anyone concerned with the state of women's ...
The texts navigate the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and provides valuable tools to help patients to put together a plan of care.
... patients with biopsyproven endometriosisa Pelvic site No. with involvement (%) Cul-de-sac 1521 (71.9) Left broad ... 476 patients with obliteration of the cul-de-sac or stage IV disease have been excluded because most patients do ...
"All of the research has reinforced that ovarian cancer is not a silent disease as was once thought and as is shown quite eloquently in this collection of stories.
Alternative treatments are also covered. Student researchers and readers will find this book easily accessible through its careful and conscientious editing and a thorough introduction to each essay. Includes charts, graphs, and tables.
The cure rate for a stage one ovarian cancer is over 90%! In this book you will: -Learn what symptoms to look for to help diagnose ovarian cancer earlier. -Get clear facts about current modalities of diagnosis and treatment.